NEDD9 and breast carcinoma: In this study, we found that ZMYND10 suppresses breast cancer tumorigenicity through upregulating miR-145-5p to inhibit the expression of oncogene NEDD9, which results in suppression of cell invasion and migration and breast cancer progression.